Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Adrian Rawcliffe > Profile

Adrian Rawcliffe

Affiliations

  • Chief Executive Officer at Adaptimmune Therapeutics Plc (ADAP), 2025-02-20
  • at Wave Life Sciences Ltd. (WVE), 2024-08-14
  • Chief Financial Officer at Human Genome Sciences Inc (HGSI), 2012-08-09
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ADAP $0.58 30,601 $17,773.06 44,327 2025-01-17 Filing
ADAP $0.57 29,096 $16,724.38 41,582 2025-01-15 Filing
ADAP $0.59 17,934 $10,543.40 25,711 2025-01-13 Filing
ADAP $0.59 12,539 $7,371.68 17,801 2025-01-13 Filing
ADAP $0.67 30,080 $20,243.84 44,848 2024-01-17 Filing